As part of the terms of the Marketing Authorisation for Daptomycin, Accord Healthcare Limited are required to ensure that all Healthcare Professionals who are likely to treat patients with daptomycin are provided with risk minimisation materials. This document contains key information to help minimise the risk of reduced susceptibility of S. aureus to daptomycin. It also provides a detailed explanation of the susceptibility testing issues, including the need for calcium in the testing medium. If you require further information about daptomycin and hard copies of the material please contact [email protected] If you have any questions or require additional information, please call Accord Healthcare Limited Medical Information Services on (0)1271 385 257.
For Healthcare Professionals